XOMA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Xoma Royalty Corp (XOMA) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has a promising royalty portfolio and a positive analyst rating, the technical indicators are bearish, recent financial performance is weak, and there are no strong trading signals or significant positive catalysts to justify immediate investment. A hold strategy is recommended until further positive developments emerge.
The technical indicators for XOMA are bearish. The MACD is negative and contracting, RSI is neutral at 37.748, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at 22.831, and resistance is at 27.094. The stock is trading below the pivot level of 24.962, suggesting downward pressure.
XOMA has completed the acquisition of Generation Bio, which is expected to enhance its asset portfolio and boost investor confidence.
Lucid Capital initiated coverage with a Buy rating and a $76 price target, citing the company's diversified royalty portfolio and long-term value creation potential.
The company's Q3 2025 financial performance showed a significant drop in net income (-148.26% YoY) and EPS (-144.03% YoY), raising concerns about profitability.
Technical indicators are bearish, and the stock trend analysis suggests a potential decline in the short term.
No recent trading activity by insiders, hedge funds, or Congress to indicate strong confidence in the stock.
In Q3 2025, XOMA's revenue increased by 29.93% YoY to $9.35M, but net income dropped significantly by -148.26% YoY to $8.98M, and EPS fell by -144.03% YoY to 0.7. Gross margin remained stable at 100%. The financials indicate revenue growth but significant profitability challenges.
Lucid Capital initiated coverage on XOMA with a Buy rating and a $76 price target. The firm highlights the company's diversified royalty portfolio and long-term value creation potential, expecting over $1B in milestones and royalties over the next 15 years.
